Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
7.86
+0.04 (0.51%)
Nov 20, 2024, 4:00 PM EST - Market closed
Zynex Revenue
Zynex had revenue of $49.97M in the quarter ending September 30, 2024, with 0.10% growth. This brings the company's revenue in the last twelve months to $193.67M, up 4.21% year-over-year. In the year 2023, Zynex had annual revenue of $184.32M with 16.54% growth.
Revenue (ttm)
$193.67M
Revenue Growth
+4.21%
P/S Ratio
1.31
Revenue / Employee
$176,059
Employees
1,100
Market Cap
250.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184.32M | 26.16M | 16.54% |
Dec 31, 2022 | 158.17M | 27.87M | 21.39% |
Dec 31, 2021 | 130.30M | 50.18M | 62.63% |
Dec 31, 2020 | 80.12M | 34.65M | 76.20% |
Dec 31, 2019 | 45.47M | 13.56M | 42.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Anika Therapeutics | 164.17M |
Lifecore Biomedical | 128.44M |
Pulmonx | 79.30M |
Electromed | 57.06M |
Inventiva | 20.65M |
Fate Therapeutics | 13.45M |
Artiva Biotherapeutics | 2.60M |
ZYXI News
- 27 days ago - Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Zynex Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 weeks ago - Zynex Sets Third Quarter 2024 Earnings Call - PRNewsWire
- 2 months ago - Zynex to Present at the HC Wainwright Global Investment Conference - PRNewsWire
- 2 months ago - Zynex Obtains FDA clearance for new Pain Management Device - PRNewsWire
- 4 months ago - DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 4 months ago - Zynex, Inc. (ZYXI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Zynex Reports Second Quarter 2024 Financial Results - PRNewsWire